Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib.
Haematologica
; 2024 May 30.
Article
in En
| MEDLINE
| ID: mdl-38813708
ABSTRACT
Not available.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Haematologica
Year:
2024
Document type:
Article
Country of publication: